维普期刊资源整合服务平台（V6.5）

56篇 您的检索式：作者名="KLEPSTAD P"

选中清除导出查看参考文献查看引证文献引用追踪共3页首页上一页第1页下一页末页 /3 跳转

	题名	作者	年代	出处	被引量
1	Starting stepⅢopi-oids for moderate to severe pain in cancer patients doseti-tration:a systematic review显示文摘	Klepstad P Kaasa S Borchgrevink PC	2011	Palliat Med2011，25，5：	1
2	The Norwegian brief pain inventory questionnaire:translation and validation in cancer pain patients显示文摘	Klepstad P Loge JH Borchgrevink PC	2002	Pain Symptom Manage2002，24，：	1
3	The Norwegian brief pain inventory questionnaire: translation and validation in cancer pain patients显示文摘	Klepstad P Loge JH Borchgrevink PC	2002	J Pain Symptom Manage2002，24，：	1
4	The 118A>G polymorphism in the human mu opioid receptor gene may increase morphine requirements in patients with pain caused by malignant disease 显示文摘	Klepstad P Rakvag TT Kaasa S	2004	Acta Anaesthesiol Scand2004，48，10：	1
5	Immediate- or sustained-release morphine for dose finding during start of morphine to cancer patients:a randomized,double-blind trial显示文摘	Klepstad P Kaasa S Jystad A	2003	Pain2003，101，12：	1
6	Concentrations ofremifentanil, propofol, fentanyl, and midazolam during rewarmingfrom therapeutic hypothermia 显示文摘	Bjelland T W Klepstad P Haugen B O	2014	Acta Anaesthesiol Scand2014，58，6：	1
7	Genetic variability and clinical efficacy of morphine显示文摘	Klepstad P Dale O Skorpen F	2005	Acta Anaesthesiol Scand2005，49，7：	1
8	Is oxycodone drricacy reflected in serum concentrations A multicenter, cross-sectional study in 456 adult cancer patients 显示文摘	Andreassen TN Klepstad P Davies A	2012	J Pain Symptom Manage2012，43，4：	1
9	Influence from genetic variability on opioid use for cancer pain:a European genetic as- sociation study of 2294 cancer pain patients显示文摘	Klepstad P Fladvad T Skorpen F	2011	Pain2011，152，5：	1
10	Starting step llI opi- oids for moderate to severe pain in cancer patients doseti- tration: a systematic review显示文摘	Klepstad P Kaasa S Borchgrevink PC	2011	Palliat Med2011，25，5：	1
11	The Brief Pain Inventory : pain' s interference with functions is different in cancer pain com- pared with noneancer chronic pain 显示文摘	Holen JC Lydersen S Klepstad P	2008	Clin J Pain2008，24，3：	1
12	Is oxycodone effi- cacy reflected in serum concentrations A muhicenter,cross- sectional study in 456 adult cancer patients 显示文摘	Andreassen TN Klepstad P Davies A	2012	Pain Sympt Manage2012，43，4：	1
13	Starting step Ⅲ opioids for moderate to severe pain in cancer patients dose titration : a systematic review显示文摘	KLEPSTAD P KAASA S BORCHGREVINK PC	2011	Palliat Med2011，25，5：	1
14	Genetic variability and clinical efficacy of morphine显示文摘	Klepstad P Dale O Skorpen F	2005	Acta Anaesthesiol Scand2005，49，7：	1
15	Starting step III opioids for moderate to severe pain in cancer patients:dose titration:a systematic review显示文摘	Klepstad P Kaasa S Borchgrevink PC		0，，05：	1
16	Sequence variations in the UDP-glucuronosyltransferase 2B7 (UGT2B7) gene:identification of 10 novel single nucleotide poly-morphisms (SNPs) and analysis of their relevance to morphine glucuronidation in cancer patients显示文摘	Holthe M Rakvg T N Klepstad P	2003	Pharmacogenomics J2003，3，1：	1
17	Genetic variability and clinical efficacy of morphine显示文摘	Klepstad P Dale O Skorpen F	2005	Acta Anaesthesiol Seand2005，49，7：	1
18	Immediate or sustained-release morphine for dose finding during start of morphine to cancer patients:a randomized,double-blind trial显示文摘	Klepstad P Kaasa S Jystad A		0，，1：	1
19	The 118 A 》 G polymorphism in the human mu-opioid receptor gene may increase morphine requirements in patients with pain caused by malignant disease显示文摘	Klepstad P Rakvag T T Kaasa S	2004	Acta Anaesthesiol Scand2004，48，10：	1
20	The Val158Met polymorphism of the human catechol-O-methyltransferase (COMT) gene may influence morphine requirements in cancer pain patients显示文摘	Rakvag TT Klepstad P Baar C	2005	Pain2005，116，12：	1

返回顶部每页显示：

共3页首页上一页第1页下一页末页 /3 跳转

互联网出版许可证新出网证(渝)字10号全国400电话 - 免长途话费

用户提示